Researchers highlight that lncROPM and its target PLA2G16 played crucial roles in sustaining breast CSC (BCSC) properties and might serve as a biomarker for BCSCs or other cancer stem cells.
[Journal of Hematology & Oncology]
Sorry, but the selected Zotpress account can't be found.
